Key Insights

Highlights

Treatment Research

1 treatments under study, led by Alprazolam

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT06874452Phase 4Recruiting

An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction

NCT06826417Not ApplicableRecruitingPrimary

Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety

Showing all 2 trials

Research Network

Common Treatments

  • Alprazolam2

Active Sponsors

  • National Taiwan University Hospital2

Top Investigators

Related Conditions

  • Satisfaction Survey2
  • Cataract Surgery Anesthesia1
  • Ophthalmology1
  • Cataract Surgery1
  • Phacoemulsification1

Activity Timeline